We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$316M
AUM Growth
-$26M
(-7.6%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
12.7%
Top 10 Holdings %
Top 10 Hldgs %
62.9%
Holding
47
New
11
Increased
11
Reduced
18
Closed
5
Top Buys
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$12.2M |
| 2 |
Pacira BioSciences
PCRX
|
+$12M |
| 3 |
Inspire Medical Systems
INSP
|
+$10.1M |
| 4 |
Medtronic
MDT
|
+$7.53M |
| 5 |
DexCom
DXCM
|
+$7.04M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
+$9.48M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$8.8M |
| 3 |
Centene
CNC
|
+$7.7M |
| 4 |
UnitedHealth
UNH
|
+$7.21M |
| 5 |
Maravai LifeSciences
MRVI
|
+$3.91M |
Sector Composition
| 1 | Healthcare | 99.39% |
| 2 | Industrials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iRhythm Holdings
IRTC
$3.72B
| $3.3M | 1.05% |
35,000
-1,030
| -3% | -$105K |
|
27
Penumbra
PEN
$12.5B
| $3.27M | 1.04% |
+13,500
| New | +$3.75M |
|
28
Shattuck Labs
STTK
$647M
| $3.23M | 1.02% |
2,123,000
+13,380
| +0.6% | +$30.5K |
|
29
Design Therapeutics
DSGN
$844M
| $2.84M | 0.9% |
+1,203,745
| New | +$5.61M |
|
30
Barrett Business Services
BBSI
$962M
| $1.93M | 0.61% |
+85,548
| New | +$1.97M |
|
31
Compass Therapeutics
CMPX
$385M
| $1.84M | 0.58% |
935,157
-148,840
| -14% | -$368K |
|
32
Alkermes
ALKS
$8.66B
| $1.82M | 0.58% |
65,000
-82,554
| -56% | -$2.42M |
|
|
LBPH
33
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.79M | 0.57% |
321,154
-413,743
| -56% | -$2.66M |
|
34
Nuvation Bio
NUVB
$2.05B
| $1.41M | 0.45% |
1,050,000
-50,000
| -5% | -$83.2K |
|
35
Agilon Health
AGL
$2.07B
| $1.4M | 0.45% |
3,163
-837
| -21% | -$378K |
|
36
Biomea Fusion
BMEA
$93.3M
| $1.3M | 0.41% |
+94,817
| New | +$1.71M |
|
37
Chemed
CHE
$6.54B
| $1.3M | 0.41% |
+2,500
| New | +$1.3M |
|
38
Evolus
EOLS
$392M
| $1.16M | 0.37% |
+126,982
| New | +$1.14M |
|
39
Zymeworks
ZYME
$1.81B
| $675K | 0.21% |
+106,405
| New | +$786K |
|
40
Erasca
ERAS
$6.61B
| $521K | 0.17% |
264,710
-1,292,660
| -83% | -$3.31M |
|
41
Elutia
ELUT
$42.4M
| $36.6K | 0.01% |
25,594
-298,831
| -92% | -$523K |
|
42
Aldeyra Therapeutics
ALDX
$116M
| – | – |
-149,511
| Closed | -$1.25M |
|
|
MODV
43
DELISTED
ModivCare
MODV
| – | – |
-16,023
| Closed | -$724K |
|
|
44
Maravai LifeSciences
MRVI
$1.04B
| – | – |
-314,300
| Closed | -$3.91M |
|
45
TriNet
TNET
$2.64B
| – | – |
0
| – | – |
|
46
The Oncology Institute
TOI
$566M
| – | – |
-455,302
| Closed | -$251K |
|
|
47
UnitedHealth
UNH
$380B
| – | – |
-15,000
| Closed | -$7.21M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA